Zonular Dehiscence Two Years After Phakic Refractive Lens (PRL) Implantation

A posterior chamber phakic refractive lens dislocated into the vitreous

SIGNIFICANCE

We present a unique cause for zonular dehiscence, which provides a pathway for subsequent dislocation of an implanted phakic refractive lens (PRL) into the vitreous cavity.

PURPOSE

To determine the cause of zonular dehiscence and to avoid similar complications after PRL implantation in the future.

CASE REPORT

A 37-year-old highly myopic patient with refraction of -24.0 DS in both eyes received PRL implantation in both eyes. In the 14-month postoperative follow-up, it was found that the PRL dislocated into the vitreous cavity. The patient then underwent phacoemulsification and vitrectomy. The patient was treated successfully. No ocular complication was found. The visual acuity of the left eye was 20/40, two weeks after surgery.

CONCLUSIONS

We report a unique cause for zonular dehiscence, and the clarification of its detailed characteristics may contribute to prevention of such a complication in the future.

Rotational Stability of a New Posterior Chamber Toric Phakic Intraocular Lens

PURPOSE

To evaluate the refractive results and rotational stability of Eyecryl toric phakic intraocular lens (pIOL).

METHODS

In this retrospective single-surgeon case series, manifest refraction, visual acuities, endothelial cell density (ECD), and pIOL rotation were evaluated over 6 months.

RESULTS

43 eyes from 23 patients were included. At 6 months, the SE was within ±0.50  D of emmetropia in 30 (70%) eyes and within ±1.00  D of emmetropia in 39 (91%) eyes. The efficacy and safety indices were 1.25 ± 0.38 and 1.41 ± 0.34, respectively. Mean ECD was 2719 ± 296 cells/mm2 at the preoperative visit and 2779.42 ± 422 cells/mm2 at the 6-month visit (p > 0.05). The mean value of absolute axis orientation error was 4.95 ± 5.28°. Mean absolute change in axis orientation between visits was less than 3° for all visit intervals. Ninety percent or more of lenses were found to rotate 5° or less between all visit intervals. None of the patients experienced a vision-threatening complication, and no patient required secondary IOL repositioning.

CONCLUSION

The pIOL appears to effectively reduce subjective manifest astigmatism and provide good visual acuity. Its position was found to be stable throughout the follow-up.

Posterior chamber phakic intraocular lens to correct myopia: long-term follow-up

PURPOSE

To evaluate the long-term safety and efficacy of a refractive phakic intraocular lens (pIOL) (PRL) to correct moderate to high myopia.

SETTING

Department of Ophthalmology, University Medicine Charité Berlin, Berlin, Germany.

DESIGN

Retrospective cohort study.

METHODS

Uncorrected (UDVA) and corrected (CDVA) distance visual acuities, refraction, intraocular pressure, endothelial cell loss, and adverse events were evaluated.

RESULTS

The study enrolled 53 eyes (mean spherical equivalent [SE] -12.17 diopters [D] ± 4.12 [SD]) of 29 patients. The mean age was 34.6 ± 9.2 years and the mean follow-up, 86 ± 21.2 months. The mean UDVA improved from 1.37 ± 0.28 logMAR preoperatively to 0.14 ± 0.19 logMAR at the last postoperative visit (P<.05). The mean CDVA improved from 0.10 ± 0.18 logMAR to -0.01 ± 0.09 logMAR (P<.05). The overall mean efficacy index and mean safety index were 0.9 and 1.21, respectively, at the last follow-up visit. The mean endothelial cell loss at the last follow-up was 6.4%. The complications were slight posterior chamber (PC) pIOL decentration (5 eyes, 9.4%), severe PC pIOL decentration resulting in pIOL removal (1 eye, 1.8%), glaucoma (4 eyes, 7.5%), clinically significant cortical lens opacification resulting in cataract surgery (4 eyes, 7.5%), clinically asymptomatic anterior subcapsular cataract formation (6 eyes, 11.3%), and retinal detachment (2 eyes, 3.8%).

CONCLUSIONS

Posterior chamber phakic pIOL implantation to correct moderate to high myopia provided predictable and stable refractive results but with a high rate of serious complications over the long term.

FINANCIAL DISCLOSURE

No author has a financial or proprietary interest in any material or method mentioned.

The posterior chamber phakic refractive lens (PRL): a review

Implantation of phakic intraocular lenses (pIOLs) is a reversible refractive procedure, preserving the patient's accommodative function with minimal induction of higher order aberrations compared with corneal photoablative procedures. Despite this, as an intraocular procedure, it has potential risks such as cataracts, chronic uveitis, pupil ovalization, corneal endothelial cell loss, pigmentary dispersion syndrome, pupillary block glaucoma, astigmatism, or endophthalmitis. Currently, only two models of posterior chamber pIOLs are commercially available, the implantable collammer lens (STAAR Surgical Co.) and the phakic refractive lens (PRL; Zeiss Meditec). The number of published reports on the latter is very low, and some concerns still remain about its long-term safety. The present article reviews the published literature on the outcomes after PRL implantation in order to provide a general overview and evaluate its real potential as a surgical refractive option.

Preliminary in vivo positional analysis of a posterior chamber phakic intraocular lens by optical coherence tomography and its correlation with clinical outcomes

Purpose

To analyze by spectral-domain optical coherence tomography the anatomical relationship of a specific type of posterior chamber phakic intraocular lens (pIOL) implanted in cases of high to moderate myopia with the adjacent intraocular structures and to correlate it with clinical outcomes.

Methods

Prospective observational case series including 18 eyes with high to moderate myopia (spherical equivalent between −5.88 and −15.75 D) of 9 patients (age range, 29–49 years) undergoing bilateral Phakic Refractive Lens (PRL, Zeiss) implantation. Postoperative visual acuity, refraction, contrast sensitivity (CS), and ocular higher order aberrations (HOA) were evaluated. Furthermore, the in vivo position of the PRL was analyzed by means of spectral domain optical coherence tomography (3D OCT-1000, Topcon). Central (CENV), temporal (TEMV) and nasal vault (NASV) were measured. Correlation of these anatomical parameters with clinical data was also investigated. Mean follow-up was 47 ± 25 months.

Results

A statistically significant visual and refractive improvement (p < 0.01) was found postoperatively. Mean postoperative CENV, NASV, and TEMV were 157.88 ± 69.93 μm, 168.29 ± 65.02 μm, and 188.59 ± 55.99 μm, respectively. Significant difference was found between NASV and TEMV (p = 0.01). No significant correlations were found between ocular aberrometric and anatomical parameters (p ≥ 0.12). CENV, NASV and TEMV correlated significantly with 6-cycles per degree (cpd) photopic CS as well as with 18-cpd low mesopic CS (r ≥ 0.57, p ≤ 0.04). Furthermore, NASV also correlated significantly with preoperative anterior chamber depth (r = −0.65, p = 0.01).

Conclusions

This posterior chamber pIOL shows a trend to nasal position, with potential impact on refractive and visual outcomes, particularly in eyes with deep anterior chambers.

Medium-term visual, refractive, and intraocular stability after implantation of a posterior chamber phakic intraocular lens to correct moderate to high myopia

PURPOSE

To evaluate the medium-term refractive and visual outcomes and the complications after implantation of a silicone posterior chamber phakic intraocular lens (PC pIOL) for moderate to high myopia.

SETTING

Oftalmar, Medimar International Hospital, Alicante, Spain.

DESIGN

Retrospective case series.

METHODS

Uncorrected (UDVA) and corrected (CDVA) distance visual acuities, refraction, and intraocular pressure were evaluated during a medium-term follow-up. Postoperative complications were also studied.

RESULTS

The study enrolled 35 eyes (mean preoperative spherical equivalent [SE] -10.25 diopters [D] ± 3.19 [SD]) of 20 patients with a mean age of 31.83 ± 8.87 years and a mean follow-up of 57.34 ± 9.24 months. The mean UDVA improved from 2.40 ± 0.20 logMAR preoperatively to 0.08 ± 0.13 logMAR at the last postoperative visit (P<.01). The mean CDVA improved from 0.11 ± 0.09 logMAR to 0.02 ± 0.09 logMAR, respectively (P<.01). The postoperative CDVA was 0.1 or better in 30 eyes (85.71%), with 22 eyes (62.86%) gaining lines of CDVA. The final efficacy index was 1.16 and the final safety index, 1.26. Regarding predictability, 34 eyes (97.14%) had an SE within ± 1.00 D and 33 eyes (94.28%) within ± 0.50 D. The complications were PC pIOL decentration (2 eyes, 5.71%), cortical lens opacification (1 eye, 2.86%), and retinal detachment (1 eye, 2.86%).

CONCLUSIONS

Implantation of a PC pIOL to correct moderate to high myopia was efficient and predictable in the medium term, with intraocular stability in most cases. New designs and criteria for PC pIOL size selection should be developed.

FINANCIAL DISCLOSURE

No author has a financial or proprietary interest in any material or method mentioned.